SIRT1 and cardiomyopathy: Fisetin exerts its therapeutic effects on DOX-induced cardiomyopathy by inhibiting ferroptosis via SIRT1/NRF2 pathway activation in the rat model of DOX-induced cardiomyopathy and H9c2 cells (Li et al., 2021).